Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.
Cabezas-Camarero S, Pérez-Alfayate R, García-Barberán V, Polidura MC, Gómez-Ruiz MN, Casado-Fariñas I, Subhi-Issa IA, Hernández JCP, Garre P, Díaz-Millán I, Pérez-Segura P.
Cabezas-Camarero S, et al. Among authors: casado farinas i.
Ther Adv Med Oncol. 2022 Jun 8;14:17588359221100863. doi: 10.1177/17588359221100863. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35694191
Free PMC article.